Simon Gronowitz pursues new opportunities outside Biovica

Associate Professor Simon Gronowitz, founder of bio-diagnostics company Biovica, has chosen to focus on research and development of new innovations outside Biovica. During his time in the company, both as CEO and as Director of Research, Simon Gronowitz contribution has been fundamental for the progress achieved. He is the inventor of DiviTum™, the most sensitive and precise test [...]

May 10th, 2013 11:00|Press Release|

Karolinska Institutet and University Hospital have shown that a simple blood test can predict breast cancer patients response to therapy

Karolinska Institutet and University Hospital have shown that a simple blood test can predict breast cancer patients response to therapy, how long treatment will be effective and survival. The results are being presented at the IMPAKT scientific conference in Brussels, May 2-4. The analysis measures growth rate and this is the first time ever that one test have documented [...]

May 2nd, 2013 11:00|News|